These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36898350)

  • 1. Proposal of novel ApoE4 inhibitors from the natural spice Cinnamon for the treatment of Alzheimer's disease: Ab initio molecular simulations.
    Shaji D; Das A; Suzuki R; Nagura Y; Sabishiro H; Kurita N
    Biophys Chem; 2023 May; 296():106990. PubMed ID: 36898350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Silico Design of Natural Inhibitors of ApoE4 from the Plant
    Shaji D; Nagura Y; Sabishiro H; Suzuki R; Kurita N
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico Identification of Novel Apolipoprotein E4 Inhibitor for Alzheimer's Disease Therapy.
    Bano S; Rasheed MA; Jamil F; Ibrahim M; Kanwal S
    Curr Comput Aided Drug Des; 2019; 15(1):97-103. PubMed ID: 30306878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an amino-terminal fragment of apolipoprotein E4 that localizes to neurofibrillary tangles of the Alzheimer's disease brain.
    Rohn TT; Catlin LW; Coonse KG; Habig JW
    Brain Res; 2012 Sep; 1475():106-15. PubMed ID: 22902767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease.
    Huang Y
    Trends Mol Med; 2010 Jun; 16(6):287-94. PubMed ID: 20537952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional Effects of ApoE4: Relevance to Alzheimer's Disease.
    Theendakara V; Peters-Libeu CA; Bredesen DE; Rao RV
    Mol Neurobiol; 2018 Jun; 55(6):5243-5254. PubMed ID: 28879423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.
    Thangavel R; Bhagavan SM; Ramaswamy SB; Surpur S; Govindarajan R; Kempuraj D; Zaheer S; Raikwar S; Ahmed ME; Selvakumar GP; Iyer SS; Zaheer A
    J Alzheimers Dis; 2018; 61(2):553-560. PubMed ID: 29172001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
    J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Silico Analysis of the Antagonist Effect of Enoxaparin on the ApoE4-Amyloid-Beta (A
    Aguilar-Pineda JA; Paco-Coralla SG; Febres-Molina C; Gamero-Begazo PL; Shrivastava P; Vera-López KJ; Davila-Del-Carpio G; López-C P; Gómez B; Lino Cardenas CL
    Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
    Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
    Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoE4: an emerging therapeutic target for Alzheimer's disease.
    Safieh M; Korczyn AD; Michaelson DM
    BMC Med; 2019 Mar; 17(1):64. PubMed ID: 30890171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.
    Butterfield DA; Mattson MP
    Neurobiol Dis; 2020 May; 138():104795. PubMed ID: 32036033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel natural structure corrector of ApoE4 for checking Alzheimer's disease: benefits from high throughput screening and molecular dynamics simulations.
    Goyal M; Grover S; Dhanjal JK; Goyal S; Tyagi C; Chacko S; Grover A
    Biomed Res Int; 2013; 2013():620793. PubMed ID: 24324968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease: unraveling APOE4 binding to amyloid-beta peptide and lipids with molecular dynamics and quantum mechanics.
    Gillet JN
    J Biomol Struct Dyn; 2021 Sep; 39(14):5026-5032. PubMed ID: 32580638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoe4 and Alzheimer's Disease Pathogenesis-Mitochondrial Deregulation and Targeted Therapeutic Strategies.
    Pires M; Rego AC
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614219
    [No Abstract]   [Full Text] [Related]  

  • 17. Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer's disease pathogenesis.
    Zhu L; Zhong M; Elder GA; Sano M; Holtzman DM; Gandy S; Cardozo C; Haroutunian V; Robakis NK; Cai D
    Proc Natl Acad Sci U S A; 2015 Sep; 112(38):11965-70. PubMed ID: 26372964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposal of Potent Inhibitors for a Bacterial Cell Division Protein FtsZ: Molecular Simulations Based on Molecular Docking and ab Initio Molecular Orbital Calculations.
    Yamamoto S; Saito R; Nakamura S; Sogawa H; Karpov P; Shulga S; Blume Y; Kurita N
    Antibiotics (Basel); 2020 Nov; 9(12):. PubMed ID: 33256135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKR Inhibition Rescues Memory Deficit and ATF4 Overexpression in ApoE ε4 Human Replacement Mice.
    Segev Y; Barrera I; Ounallah-Saad H; Wibrand K; Sporild I; Livne A; Rosenberg T; David O; Mints M; Bramham CR; Rosenblum K
    J Neurosci; 2015 Sep; 35(38):12986-93. PubMed ID: 26400930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific interactions between tau protein and curcumin derivatives: Molecular docking and ab initio molecular orbital simulations.
    Sato R; Vohra S; Yamamoto S; Suzuki K; Pavel K; Shulga S; Blume Y; Kurita N
    J Mol Graph Model; 2020 Jul; 98():107611. PubMed ID: 32276176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.